Abstract
The pharmacologic treatment of schizophrenia is characterized by excessive use of antipsychotic polypharmacy, which reflects a gap between evidence and practice. The aim of the present study was to investigate regional differences in treatment setting characteristics and in physician and nurse attitudes toward antipsychotic polypharmacy and clinical guidelines.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Clinical Psychiatry |
Vol/bind | 71 |
Udgave nummer | 11 |
Sider (fra-til) | 1457-64 |
Antal sider | 8 |
ISSN | 0160-6689 |
DOI | |
Status | Udgivet - 1 nov. 2010 |